The Cancer Prevention and Control Program (CPC) is a longstanding component of the University of Arizona Cancer Center that is characterized by its highly collaborative, multidisciplinary team science designed to reduce cancer rates and related burden. The scientific goal of the CPC is to develop and implement highly interactive cancer prevention and control research that will lead to progressive reductions in cancer incidence, morbidity, and mortality. The Cancer Prevention and Control Program is led by H-H. Sherry Chow, PhD, and Cynthia Thomson, PhD, RDN, leaders who support our cancer prevention scientists in who collectively conduct translational research that spans from the laboratory to the clinic to the community.

The CPC fosters high impact multidisciplinary and translational science that serves the University of Arizona Cancer Center (UACC) catchment area. Scientific goals are accomplished with integration of faculty from across the campus of the University of Arizona (UA) and are operationalized through cancer-site or theme specific team science. 

The Program Members’ research aims focus on three major themes:

Identify biological, environmental, and lifestyle behavioral factors, as well as gene-environment interactions associated with cancer risk, morbidity, and mortality.

Conduct laboratory, translational, and clinical research studies to identify potential targets for cancer prevention and to evaluate chemoprevention strategies.

Conduct behavioral, psychosocial, and QOL research to develop and test interventions to reduce cancer incidence, morbidity, and mortality with an emphasis on cancer survivorship.

Program Goals

  • To advance cancer prevention knowledge and inform on interventions through epidemiological science. The CPC will utilize epidemiological approaches to identify biological, environmental, and lifestyle factors, as well as gene-environment interactions associated with cancer risk, morbidity, and mortality.
  • To evaluate novel chemoprevention compounds and biomarkers that will impact cancer prevention. The CPC will conduct laboratory, translational, and clinical research studies to identify potential targets for cancer prevention and to evaluate chemoprevention strategies, including pharmaceuticals, nutraceuticals, and vaccines.
  • To test behavioral, psychosocial, and quality of life (QOL)-targeted interventions with high potential to reduce cancer risk and improve cancer outcomes. The CPC will conduct behavioral, psychosocial, and quality of life research to develop and test interventions to reduce cancer incidence, morbidity, and mortality with an emphasis on cancer survivorship.

These aims represent key thematic areas of research that work in synergy to advance scientific knowledge and Program impact. Researchers operationalize their efforts through interdisciplinary teams organized by cancer type or theme and include women’s cancers (breast, ovarian), colorectal cancer, prostate cancer, liver cancer and skin cancer. Studies are designed to integrate cutting-edge research activities across the continuum of cancer prevention and control and to address special populations and cancer burdens in the catchment area.